Klivira
Request demo

Optimizing Fertility (REI) Denial Management

Klivira automates fertility (REI) denial management, addressing the unique complexities of reproductive endocrinology claims to safeguard revenue and ensure patient access.

Managing denials in fertility (REI) practices presents distinct challenges, from high-cost IVF cycles and specialty drugs to complex medical necessity criteria for fertility preservation. Manual denial workflows lead to significant rework, timely-filing breaches, and lost revenue. Klivira transforms this process, providing an automated, evidence-driven approach to appeal and resolve fertility-related claim denials.

The Unique Challenges of Fertility Denials

Fertility treatments often involve multi-stage procedures and high-cost specialty drugs, making prior authorization and subsequent denial management particularly intricate. Denials frequently stem from medical necessity disputes for IVF cycles, coverage limitations for fertility-preservation procedures, or formulary restrictions for fertility specialty drugs. Each denial requires precise denial reason parsing and targeted appeal strategies to address payer-specific policies and clinical guidelines.

Automated Denial Ingestion and Categorization for REI

  • Klivira ingests fertility-related denials from all channels, including X12 835 for billed services, X12 277 for pre-service PA denials, payer portals, and Da Vinci PAS `ClaimResponse` for conformant payers.
  • Our system normalizes X12 CARC/RARC codes and payer-specific local variations into a uniform denial reason taxonomy, specifically tailored to common fertility denial patterns.
  • Denials related to IVF cycles, fertility specialty drugs, and fertility preservation are automatically categorized and routed to the appropriate workflow: claim correction, appeal, or peer-to-peer review.

Intelligent Appeal Generation for Fertility Services

For clinical-necessity denials common in fertility services, Klivira automates the appeal letter generation process. Our platform leverages FHIR-based EMR integrations to pull relevant clinical documentation, such as updated lab results, imaging reports, and physician notes, directly into the appeal packet. This ensures that appeals for IVF cycles, fertility preservation, or specialty drug coverage are submitted with the strongest possible clinical evidence, adhering to payer-specific appeal-pathway requirements.

Timely Filing and Status Tracking for High-Value Cases

  • Klivira enforces per-payer timely-filing windows for all fertility-related appeals, proactively surfacing deadlines to prevent missed appeal opportunities for high-value treatments.
  • Our system tracks appeal status across payer portals and X12 277 transactions, providing real-time visibility and auto-escalation for appeals that remain unchanged for configurable thresholds.
  • This automation significantly reduces the risk of 'lost-to-follow-up' appeals, a common operational failure mode in manual denial management workflows.

Driving Upstream Improvements in Fertility PA

Beyond resolving individual denials, Klivira provides comprehensive reporting and pattern detection specific to fertility services. We surface denial reason patterns by payer, service line (e.g., IVF vs. IUI), and provider. This actionable intelligence feeds back into your upstream prior authorization processes for fertility, allowing your team to identify root causes, refine PA submission strategies, and ultimately reduce future denial rates for high-volume PA categories like IVF, fertility specialty drugs, and fertility preservation. This data-driven approach aligns with industry benchmarks from sources like the CAQH Index and MGMA surveys, which highlight the significant administrative costs associated with manual denial rework.

Frequently asked questions

How does Klivira handle denials for IVF cycles?

Klivira automates the intake and categorization of IVF-related denials, leveraging EMR integration via FHIR to assemble comprehensive appeal packets with supporting clinical documentation. Our system tracks timely filing and submits appeals through the appropriate payer channels, ensuring that complex IVF denials are managed efficiently.

Can Klivira automate appeals for fertility specialty drugs?

Yes, Klivira's platform is designed to manage denials for fertility specialty drugs. We parse denial reasons, gather necessary clinical evidence from the EMR, and generate appeal letters that address formulary restrictions or medical necessity criteria, streamlining the appeal process for these high-cost medications.

What EMR data does Klivira use for fertility denial appeals?

Klivira integrates with your EMR via FHIR to pull relevant clinical data for fertility denial appeals. This includes patient history, diagnostic results, treatment plans, and physician notes that support the medical necessity of IVF, IUI, fertility preservation, or specialty drug therapies.

How does Klivira address timely filing for fertility-related denials?

Klivira proactively enforces per-payer timely-filing windows for all fertility-related appeals. Our system tracks deadlines and provides alerts, ensuring that appeals for high-value fertility treatments are submitted within the required timeframes, preventing lost revenue due to administrative oversight.

Does Klivira provide insights into common fertility denial patterns?

Absolutely. Klivira's reporting and analytics capabilities identify denial patterns specific to fertility services, by payer, procedure type (e.g., IVF, IUI), and provider. This actionable intelligence helps your team understand root causes and optimize upstream prior authorization processes to reduce future denials.

Related coverage

Other fertility-reproductive prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo